Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

Cyclophosphamide 1492 Cisplatin 1415 Paclitaxel 1319 Radiotherapy 1261 Carboplatin 1250 Gemcitabine 1215 Docetaxel 1111 Bevacizumab 1031 Fluorouracil 895 Doxorubicin 792 Dexamethasone 748 Rituximab 720 Capecitabine 717 Oxaliplatin 701 pembrolizumab 680 Etoposide 678 Irinotecan 636 Filgrastim 621 Cytarabine 586 Leucovorin 579 Nivolumab 560 Vincristine 515 Prednisone 475 Cetuximab 465 Bortezomib 459 Erlotinib Hydrochloride 456 Trastuzumab 447 Methotrexate 438 Lenalidomide 428 Pemetrexed 420

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × MK-4166 × Clear all

NCT02132754 2021-01-28

MK-4166-001

Merck Sharp & Dohme LLC

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡